Distribution September 26, 2018 Frequently Asked Questions – 340B Program 4 Minute Read The 340B program is subject to increasing scrutiny as pharmaceutical manufacturers search for solutions to identify and act on non-compliance such as diversion and duplicate discounts. This post is...
Channel August 20, 2018 Opioid Crisis Exposes Vulnerabilities in Suspicious Order Monitoring 4 Minute Read The American opioid crisis exposed gaps in the reporting systems designed to flag suspicious orders of pharmaceutical products classified as controlled substances. Pharmaceutical manufacturers are now facing increased scrutiny...
Patient Access August 3, 2018 3 Key Opportunities to Improve Specialty Patient Initiation 3 Minute Read There are several ways specialty brands can improve patient initiation by implementing data-driven patient support strategies. Successful interventions to streamline patient initiation have the potential to speed Time to...
Managed Services July 27, 2018 The Economics of Rare Disease and Implications for Payer Contract Strategy 3 Minute Read Rare diseases affect 30 million people in the United States, which roughly equates to 10% of the population. In 2017, 40% of the novel drugs approved by the FDA...
Patient Access March 21, 2017 Specialty Pharmacy Status/Sub-Status Analysis Highlights Inconsistencies in Data Quality 3 Minute Read Brandon Underwood offers a sneak peek at IntegriChain's upcoming Specialty Analytics benchmark report. IntegriChain examined the quality and granularity of status/sub-status data across 40 specialty pharmacies representing different classes...
Channel June 2, 2016 Leveraging Scorecard Analytics to Optimize Changes to DSAs 2 Minute Read In my last post, I explored how IntegriChain Scorecard Analytics can be used to validate whether the implementation of Distribution Service Agreements (DSAs) drives channel performance. In this post, we will...
Patient Access May 27, 2016 Trends in Specialty Pharmacy Channel Design – Takeaways from Asembia Specialty... 3 Minute Read The Asembia (formerly known as Armada) Specialty Pharmacy Summit is fast becoming the pharmaceutical industry’s most important meeting. This year’s Las Vegas show boasted a record attendance of nearly...
Channel April 6, 2016 IntegriChain Continues to Lead in Automated, End-to-End Management of Pharma Distribution... 2 Minute Read Distribution Service Agreements (DSAs) have continued to evolve over recent years especially as they relate to how they evaluate channel performance. For the most part, manufacturers structure the agreements...
Channel March 2, 2016 867 Master Data and Channel Analytics Has Emerged as the Best... 2 Minute Read By now, government price departments are well underway towards implementing the Final Average Manufacturer Price (AMP) Rule recently issued by the Center of Medicare and Medicaid Services (CMS). AMP...
